Respiratory / New drug         
SYN010

SYN010 is a combinational product with inhaled corticosteroid and long acting beta-2 agonist (ICS+LABA) and have a similar formulation to the Symbicort by using iLEF platform. The global clinical study is proceeding and international submission dossier is under preparing.